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Introduction. To report a case of Primary Ocular Adnexal MALT Lymphoma (POAML) and perform a review of the literature about
this neoplasia focusing on the role of radiotherapy and its toxicity. Case presentation A 78-year-old man with a conjunctival
POAML, without systemic disease, was treated with intralesional Rituximab into a clinical trial, with an initial good response but
local progression associated to haemorrhage after a few cycles. The patient underwent salvage radiotherapy using a direct 6MeV
electrons ﬁeld with a circular 5 cm applicator, receiving a total dose of 30 Gy (2-Gy per fraction) achieving a good response. The
acute toxicity was mild periorbital erythema, and excessive tearing or swelling which did not require any treatment intervention.
Results. POAML is a rare disorder that represents approximately 8% of all extranodal lymphomas and has a relatively indolent
course, remaining localized during a long time. Although there is no consensus regarding to the initial management of POAML,
radiotherapy has been considered themost effective treatment for localized disease. Radiotherapy for localizedMALT lymphoma,
despite offering an excellent local control, might not be useful in preventing systemic relapses, occurring in 5–45% of patients.
The efﬁcacy of the combination of radiotherapy and chemotherapy has not been fully investigated. There are large differences
in the total doses reported, ranging from 20 to 54Gy, although most authors recommend a total dose of 30–34Gy with 1.5–2Gy
per fraction. The delivery of 30Gy in conventional fractions to the orbit is considered safe, except for the potential development
of cataracts. Although MALT lymphomas occasionally produce distant involvement, primary tumors do not usually inﬁltrate the
surrounding normal tissues. Therefore, it is not always necessary to include the whole orbit in the radiation ﬁeld. In this case
the whole conjunctiva was irradiated to avoid the local relapse.
Conclusion. Radiation therapy is effective and safe for patients with POAML, achieving a good local control with a reasonable
toxicity rate. Although some patients developed cataracts after irradiation, visual acuity was preserved in all series. A total dose
of 30Gy may be recommended for the treatment, but further investigations are required to deﬁne the optimal dose.
http://dx.doi.org/10.1016/j.rpor.2013.03.340
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Introduction. According to the relevant literature extranodal primary lymphomas of parotid are rare. Moreover if we consider that
its incidence is very lowand that the only cases reported are usually non-Hodgkin lymphomas associatedwith immunodeﬁciency
(HIV) or autoimmune diseases (Sjögren). Collected in world literature are published about 30 cases of primary Hodgkin’s disease
of parotid. The most frequent variety lymphocyte-predominant HD. Because of the rarity of the variety lymphocyte-rich classical
HD (<5% total), this is one of the few cases reported to date, CASE a man of 44 years old with no prior medical or surgical relevant
history. He consulted the G.P. about a mass located in the right parotid region without B symptoms in May/2012 then He was sent
to the referral hospital to assess possibility of Maxillofacial Surgery. The diagnosis of low grade B-cell lymphoma suspected after
FNA. Subsequently, it was recommended eliminating this right parotid mass held on 07.12.2012, under general anesthesia, using
preauricular incision and enucleation of a node approx. 2 cm and located in the upper lobe of the right parotid. After histological
examination macroscopic a lymph node was identiﬁed and removed completely covered by a capsule of ﬁbrous tissue with tissue
debris salivary. Microscopic histological analysis veriﬁed the presence of Hodgkin lymphoma, lymphocyte-rich as now classiﬁed
2009. Following the usual protocol, we proceeded to do the staging for what was useful PET-CT. This study was conducted in
September 2012 and identiﬁes a pathologically increased glucose metabolism in the right parotid gland of 2.7 cm×1.5 cm. Up
to 6 SUV. The rest of the extension study was negative for detecting lymphoma. After the study was considered as Hodgkin
lymphoma stage I AE parotid Treatment: The patient began receiving systemic chemotherapy from 14/10/2012 until completing
4 cycles of ABVD chemotherapy scheme, with complete metabolic PET TAC response. Subsequently, the patient was treated with
involved ﬁeld radiotherapy. The patient reaching 30Gy as usual fractionation with excellent tolerance.
http://dx.doi.org/10.1016/j.rpor.2013.03.341
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Introduction. Lymphomas may rarely be detected as a form of primary lung disease, although they usually affect the lungs sec-
ondarily. The natural history of PPNHL appears to be slow compared with other low grade lymphomas, and their treatment is
controversial.
Objective. Description of a case of primary pulmonary Lymphoma in a woman of 70 years.
